GlaxoSmithKline, Pharmacology, Pharmaceutical industry, Pharmacy, Novartis, AstraZeneca

“At EPFL, I soon felt right at home.”

On Oct 8, 2020
@EPFL_en shared
Leila Schwery-Bou-Diab, Vice President of Value Chain Management for @JNJNews, is one of the winners of the 2020 Alumni Awards, marking over 20 years of professional achievement since she graduated from EPFL. @epflalumni https://t.co/Q3FHL2IC6v https://t.co/6SN961rsV4
Open

Every year EPFL hands out Alumni Awards to two graduates who have led exceptional careers. Leila Schwery-Bou-Diab, currently the Vice President of Value Chain Management for Johnson & Johnson’s pharmaceutical business, is one of this year’s winners – marking over 20 years of ...

actu.epfl.ch
On Oct 8, 2020
@EPFL_en shared
Leila Schwery-Bou-Diab, Vice President of Value Chain Management for @JNJNews, is one of the winners of the 2020 Alumni Awards, marking over 20 years of professional achievement since she graduated from EPFL. @epflalumni https://t.co/Q3FHL2IC6v https://t.co/6SN961rsV4
Open

“At EPFL, I soon felt right at home.”

“At EPFL, I soon felt right at home.”

Every year EPFL hands out Alumni Awards to two graduates who have led exceptional careers. Leila Schwery-Bou-Diab, currently the Vice President of Value Chain Management for Johnson & ...

Comparing Reports: Top Drug Companies, Corporation Reputations and Marketing Budgets

Comparing Reports: Top Drug Companies, Corporation Reputations and Marketing Budgets

The public’s perception of the drug industry can be confusing. Recent studies take a hard look at the industry from different perspectives.

For pharma services firms, big assets can pose major risks

For pharma services firms, big assets can pose major risks

Despite a spotty track record, contract development and manufacturing organizations push on in their acquisition of drugmakers' factories

Which big pharma firms are best at digital?

Which big pharma firms are best at digital?

New research by The Worldcom Public Relations Group has ranked pharmaceutical companies according to their usage of digital channels – with Bayer, Pfizer and Boehringer Ingelheim coming out ...

Exclusive: big pharma rejected EU plan to fast-track vaccines in 2017

Exclusive: big pharma rejected EU plan to fast-track vaccines in 2017

World’s top drug firms turned down proposals for work on pathogens like coronavirus

Health data Switzerland, land of big pharma, tries to reel in AI startups

Health data Switzerland, land of big pharma, tries to reel in AI startups

Artificial intelligence could do wonders for hospitals: sharper diagnosis, fewer admin chores and more time spent with patients. 

Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry

Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry

The pharmaceutical business is perhaps the only industry on the planet, where to get the product from idea to market the company needs to spend about a decade, several billion dollars, and ...

Drugmakers getting bolder in fight over 340B drug discounts

Drugmakers getting bolder in fight over 340B drug discounts

Drug manufacturers are getting more aggressive in their moves to restrict access to 340B drugs as legal experts say the Trump administration is not stepping in.

A Deal on Drug Prices Undone by White House Insistence on ‘Trump Cards’

A Deal on Drug Prices Undone by White House Insistence on ‘Trump Cards’

The White House and the pharmaceutical industry were nearing a major deal to lower drug prices. Then the administration demanded that $100 cash cards be sent to millions of seniors before ...

The reinvention of Novartis

The reinvention of Novartis

Transforming a pharma conglomerate

Digital health start-up once worth $1.5 billion is racing to keep lights on as investors flee

Digital health start-up once worth $1.5 billion is racing to keep lights on as investors flee

Proteus Digital Health has struggled to find a market for its digestible sensors and wearable patches, leaving the company desperate for cash.

What future for pharma in a digital world?

What future for pharma in a digital world?

As the industry grapples with the implications of technological changes, Dr Paul Tunnah reflects on a roundtable he recently ran with heads of innovation, communication and digital strategy ...

German company Merck doubles production in Catalonia after €40M investment over the last 4 years

German company Merck doubles production in Catalonia after €40M investment over the last 4 years

This relationship with Catalonia deepened in 1974 when the German firm opened a production plant in Mollet del Vallès (Barcelona). The company's commitment to the Mollet del Vallès plant is ...